Research and Reviews of Infectious Diseases

Dr. John D. Bullock is The Brage Golding Distinguished Professor of Research at Wright State University of Boonshoft School of Medicine,USA. He held a clinical faculty position at Stanford University before coming to Wright State, where he served as professor and chair of the department of ophthalmology, professor of physiology and biophysics, associate professor of microbiology and immunology. He also served as a lecturer in Law and Medicine at the University Of Dayton School Of Law. He discovered three new causes of blindness and elucidated the etiology and/or description of eight different retinopathies. His research influenced the market withdrawal of two general anesthetics, a warning label for a pharmaceutical agent whose inappropriate use resulted in blindness, and a Consumer Products Safety Commission-mandated warning label. In 2011 he received the Outstanding Scientific Project Award from the Vision Care Section of the American Public Health Association. For the past 10 years, Dr. Bullock has been investigating a worldwide outbreak of infectious blindness (published in the New England Journal of Medicine), which was traced to an improperly and bottled contact lens solution.

Dr. James P Chambers is a professor of Biochemistry, Department of Biology at The University of Texas, San Antonio, USA; and also Adjunct Professor of Biochemistry at University of Texas Health Science Center at San Antonio, USA. After obtaining his Ph. D., Dr. Chambers was an NIH postdoctoral training fellow in The Department of Biochemistry (1976-1978), The University of Pittsburgh School of Medicine, Pittsburgh, completing his postdoctoral training in the Department of Biochemical Genetics (1978-1979), Washington University School of Medicine, St. Louis, USA. Prior to his joining the faculty of The University of Texas at San Antonio in 1984, Dr. Chambers served as Co-Director of the Metabolic Disease Laboratory of the Department of Pediatrics, The University of Texas Health Science Center at Houston (1979-1984). He served as interim Director of the Division of Life Sciences (1991-1992). Dr. Chambers has a wide array of research interests, has garnered continued peer-reviewed research support for his laboratory activities from Federal, Department of Defence, and private agencies over these many years, is a recipient of numerous research awards, and has published extensively in peer-reviewed scientific journals.

Dr. Victoria Bengualid is a Director and Associate Profressor, Department of Internal Medicine Albert Einstein College of Medicine, New York, United States of America. Dr. Victoria Bengualid is an Affiliate Associate Medical Professor in the Department of Clinical Medicine, CUNY school of Medicine. After graduating medical school at New York University School of medicine, She completed an internal medicine residency at Montefiore Hospital in the Bronx, New York followed by an Infectious Disease fellowship at the same institution. She decided to stay in the Bronx, and She have been working about 20 years as an Infectious Disease attending at St. Barnabas Hospital in the Bronx. There not only do she see patients but also engage in some retrospective and some prospective research projects.

Dr. Nigel Yarlett is a Distinguished Professor of Biochemistry and Director of Haskins Laboratories at Pace University, New York, United States of America. He recevied his BS and PhD from Cardiff University, Wales. Did post doctoral research at The Rockefeller University, New York, and The Institute of Animal Physiology, Cambridge University. Awarded the Hutner Prize in Protozoology (1995); Fellow of the Society of Fellows of Pace University (1996); a Fellow of the Royal Society of Chemistry (2012). Member of the American Society of Biochemistry and Molecular Biology and The New York Academy of Science. Over 100 publications in the area of protozoan biochemistry. Demonstrated the presence of hydrogenosomes in Rumen protozoa and Rumen fungi. The role of oxygen in the resistance of Trichomonas vaginalis to metronidazole. The unique polyamine bichemistry of Trichomonas vaginalis and Cryptosporidium parvum. The ability of oxoboroles to cure mouse model trypanosomiasis. Novel culture method for Cryptosporidium parvum. Funded by the National Institutes of Health; Drugs for Neglected Diseases initiative, and the Bill and Melinda Gates Foundation. Current research centers on use of a hollow fiber culture system to evaluate chemotherapeutic agents for the treatment of cryptosporidosis. Compounds can be evaluated over several days or weeks of exposure and preliminary pharmacokinetic and pharmacodynamic data determined simultaneously. The system permits determination of surviving populations that can be examined for potential drug resistance mechanisms.

Dr. Eunok Jung is a Professor in the Department of Mathematics at Konkuk University since 2002. Eunok completed her Ph.D. at Courant Institute, New York University and her undergraduate and mater degrees at Korea University. Her research interests lie in the area of mathematical modeling of infectious diseases, cardiovascular diseases, optimal control theory, and biofluid dynamics.She has collaborated actively with researchers in several other disciplines of prevention medicine, medical science, engineering and biology. Eunok has served on roughly thirty conference and workshop program committees. She has served as a general director and a vice-president in the Korean Society for Industrial and Applied Mathematics (KSIAM) from 2005 to 2014, a board member in Korean Mathematical Society (KMS), Korean Society for Mathematical Biology, Korean Women in Mathematical Sciences.

Dr. Cheorl-Ho Kim is a professor in Department of Biological Sciences, College of Science, Sungkyunkwan University, Korea. He has successfully completed his Administrative responsibilities as Genome Program Head, Korea Research Institute of Bioscience and Biotechnology on 1990-1996 and Chairman, Department of Biochemistry and Molecular Biology, COM, Dongguk University during 1996-2006. His research has included the molecular biology of gene expression, Golgi glycosyltransferase, oncognenesis, cancer metastasis and angiogenesis. He has authored 362 research articles/books with H-index 37. He is a member of International Scientific Advisory Board Member, International Symposium for Glycosyltransferases (GlycoT 2006), IUBMB symposium, Tsukuba and International Symposium for Glycosyltransferases (GlycoT 2008), Emory University, GA, USA, International Biochemical and Molecular Engineering 2013, San Antonio, TX, USA, and 5th World Congress of Biotechnology 2014, Valencia, Spain. He was served as a Key Note Speaker of 5th WCB. Dr. Cheorl-Ho Kim research interests are Cancer biology, Angiogenesis, Leukaemia, Gene expression and transcriptional regulation, Glycosyltransferase, Cell cycle, apoptosis, carcinogenesis, oncogenic transformation, growth factor-receptor interaction; cell differentiation; carbohydrate antigen; cell adhesion and angiogenesis; signal transduction.

Dr. Samuel N Grief is an Associate Professor in Department of Family Medicine at Chicago College of Medicine, University of Illinois, USA. Dr. Samuel initial career venue was in rural Canada. He then transferred to a practice in rural America. He is an expert in making home visits, also known as house calls. As a result of his eight years in these practice settings, He learned many skills and primary care "tricks of the trade" which he envision sharing with students during the span of the grant. For the past several years, he has been a teaching faculty within the PCM Scholars Program, partnering with fledgling medical students in developing continuity of care patient experiences. He envisions doing something similar along these lines, identifying patients in need within our designated rural areas and making house calls and establishing an ongoing relationship with patients that capture the essence of patient-centred medicine. In summary, he anticipates a strong interest among students in our field of study and look forward to co-leading the project with fellow collaborators.

Dr. Guirong Wang is an Associate Professor in Department of Surgery (Cell and Molecular Biology) at Upstate Medical University, The State University of New York, USA. He was working in this filed for past 15 years. He also worked as Associate Professor of Paediatrics in The Pennsylvania State University College of Medicine, USA. Dr. Guirong Wang was Natural Science and Engineering Research Council Awardee (1997- 1998) in molecular genetics and protein engineering, University of Guelph, Guelph, Canada. He has a member ship in Professional Societies like American Association for Advancement of Science, The America Physiological Society, The American Thoracic Society and The shock Society. He has International Patent on "Surfactant prevention of lung complications from cancer chemotherapy."

Dr. Koti Sreekrishna is a senior scientist in the Global Biotechnology division at the Procter & Gamble Company since 1997. PhD Biochemistry (1978), Indian Institute of Science, Bangalore (India). Prior to that worked in Biotechnology departments at Marion Merrell Dow for four years and Phillips Petroleum Company for eight years. Has early on conducted Post-Doctoral research on fatty acid desaturase at the Baylor College of Medicine and yeast molecular genetics at the University of Kentucky. Research interests include sensorial biology, Rhino and Influenza virus, Pichia pastoris protein expression system, molecular interaction, skin and hair biology, laundry enzymes and retinol binding proteins.

Dr. Jean-Paul Joseph Gonzalez joined Metabiota, Inc. as Senior Staff Scientist, perpetuating his expertise on emerging viral disease, biosafety, biosecurity and biosurveillance, mentoring and training young scientists from developing countries. He has published more than 300 scientific papers, chapters and books. His main fields of research encompass the fundamentals and domains of disease emergence, viral disease eco-epidemiology (i.e. arbovirology, viral hemorrhagic fevers). He has led field and laboratory teams of researchers with institutes of country partners, including Brazil, Central African Republic, Gabon, Senegal, Thailand, Laos, among others. He worked at the Centers for Disease Control and Prevention in Atlanta and Fort Collins, and as a visiting professor at the Yale University Arbovirus Research Unit, has been involved in high security laboratory practices and research, early development of geographical information systems applied to infectious diseases. He and his teams have identified new pathogens for humans and animals, and have developed tools and strategies for biosurveillance, control and prevention of highly infectious transmitted disease. He has revisited the spread and dynamics of several viral hemorrhagic fevers, giving spatial and temporal dimensions. He has developed several scientific concepts and research strategies for health (e.g.: long lasting co-evolution of germs and hosts).

Dr. Massimo Ciccozzi is an Associate professor in Epidemiology and Statistic University of Biomedical Campus in Rome and Researcher in epidemiology, bio statistics and viruses evolution at Italian National Institute of Health (Department of Infection Diseases) Rome Italy. He is a WHO expert consultant for Serbia and Montenegro for planning and organising second generation HIV surveillance systems, Italian Expert consultant for surveillance systems and molecular epidemiological studies in China and Expert consultant in epidemiology in Montenegro. He is the Director and teacher in several courses in Epidemiology, Bio statistics, Phylogenetic and evolutionary analysis in Italian and Foreigner University and Author of more than 180 publications. Dr. Massimo Ciccozzi research is mainly focused on epidemiology, bio statistics and viruses’ evolution, epidemiology and surveillance systems, molecular epidemiology and phylogeny on HIV, evolutionary studies on SARS and Avian Flu.

Dr. Gilbert Lefevre is a Senior Scientist Neurosciences, Musculoskeletal Disorders, Infectious Diseases, Tropical Medicines, Oncology Novartis NIBR, DMPK, Basel, Switzerland. Dr. Lefevre has twenty-five years pharmaceutical development experience with expertise in Translational Sciences, Clinical Pharmacology, Pharmacokinetics, Pharmacodynamics and Dose/Exposure-Response relationships. Dr. Lefevre also has regulatory experience, including approvals at WHO (list of essential medicines) with nine successful New Drug Applications in cardiovascular disorders, oncology, neuroscience, infectious diseases and tropical medicines. His expertise also includes drug development in pediatrics, and he established partnerships with Academia in Africa, Asia and USA. Dr. Lefevre was co-awarded the Prix Galien US in 2010 for the antimalarial Coartem/Riamet. Dr. Lefevre received a PhD in Biology and Life Sciences from University of Paris, France, and was trained in General Immunology at Pasteur Institute.

Dr. Maria Teresa Mascellino works as aggregate professor in the Department of Public Health and Infectious Diseases.She has completed her MD at the age of 25 years in Rome during the period of 1980 and specialization studies in Microbiology and Infectious Diseases from Sapienza University of Rome (Italy). She is responsible of the Simple Operative Unit "Microbiological analyses in the immuno compromised hosts". She has published about 100 papers in reputed journals and has been serving as an editorial board member of repute.